Pharma-Bio Serv (OTCMKTS:PBSV) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) announced its earnings results on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02), Zacks reports. Pharma-Bio Serv had a negative net margin of 0.86% and a negative return on equity of 0.66%.

Pharma-Bio Serv Stock Performance

OTCMKTS PBSV traded up $0.08 on Monday, reaching $0.57. The stock had a trading volume of 3,793 shares, compared to its average volume of 5,019. The stock has a market cap of $12.94 million, a P/E ratio of -56.50 and a beta of 0.64. Pharma-Bio Serv has a 12-month low of $0.43 and a 12-month high of $1.36. The business’s 50-day moving average price is $0.53 and its 200 day moving average price is $0.54.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.